Eastern Podiatry Llc Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 231 S Washington St, Millsboro, DE 19966 Phone: 718-972-5000 Fax: 718-972-3774 |
News Archive
A less aggressive type of surgery designed to spare healthy organ tissue is used infrequently to treat early-stage kidney cancer, according to researchers at the University of Michigan Comprehensive Cancer Center.
SCAN Health Plan, the country's fourth largest not-for-profit Medicare Advantage plan, was among the healthcare organizations honored by the Los Angeles Business Journal (LABJ) for its outstanding efforts in serving the community. The prestigious Healthcare Leadership Award ceremonies are conducted annually by the LABJ to recognize locally based companies whose community outreach programs help make the city a better place to live.
Capsa Solutions, a leading provider of storage, processing and transport products, has announced the acquisition of Artromick Mobile Solutions Group and their comprehensive line of medication, medical and mobile computing carts for the extended and acute healthcare sectors. Artromick Mobile Solutions Group was previously owned by Sterling Partners, a Chicago and Baltimore-based private equity firm.
The American Society of Bariatric Physicians (ASBP) is concerned that the FDA advisory panel recommended lowering the BMI requirement for lap-band surgery, while the FDA recently denied two new obesity medications. Bariatric surgery is drastic and expensive and carries higher morbidity and mortality risks than lifestyle interventions or medication. Patients who could have otherwise lost weight in a non-surgical medical bariatric program may now be encouraged to skip medical therapy and jump directly to surgery.
Boston Scientific Corporation today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration and CE Mark approval to market its Advanix™ Biliary Plastic Stents for the treatment of biliary strictures, including biliary stone disease, benign biliary strictures, and suspected and confirmed malignancies in the biliary system. The product is now available in Europe and other international markets; the Company plans to launch it in the U.S. this quarter.
› Verified 6 days ago